• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.

作者信息

van Ommen-Nijhof A, Retèl V P, van den Heuvel M, Jager A, van Harten W H, Sonke G S

机构信息

Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

Department of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Health Technology and Services Research (HTSR), University of Twente, Enschede, the Netherlands.

出版信息

Ann Oncol. 2021 Oct;32(10):1212-1215. doi: 10.1016/j.annonc.2021.08.1747. Epub 2021 Aug 13.

DOI:10.1016/j.annonc.2021.08.1747
PMID:34400293
Abstract
摘要

相似文献

1
A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.一项用于研究昂贵药物高效使用的循环研究基金：大机构持续运转。
Ann Oncol. 2021 Oct;32(10):1212-1215. doi: 10.1016/j.annonc.2021.08.1747. Epub 2021 Aug 13.
2
EPI Revolving Fund: quality vaccines at low cost.扩大免疫规划周转基金：低成本的优质疫苗。
EPI Newsl. 1997 Aug;19(4):6-7.
3
Revolving drug funds: conducting business in the public sector.循环药物基金：在公共部门开展业务
Soc Sci Med. 1986;22(3):335-43. doi: 10.1016/0277-9536(86)90132-2.
4
[PHARMACEUTICAL SUPPLIES IN THE DUTCH SICK FUND].
Tijdschr Soc Geneeskd. 1964 Jan 10;42:30-2.
5
Three big questions facing the World Bank's new pandemic fund.世界银行新的大流行病基金面临的三大问题。
BMJ. 2022 Nov 25;379:o2857. doi: 10.1136/bmj.o2857.
6
How to establish a successful revolving drug fund: the experience of Khartoum state in the Sudan.如何建立一个成功的循环药物基金：苏丹喀土穆州的经验
Bull World Health Organ. 2009 Feb;87(2):139-42. doi: 10.2471/blt.07.048561.
7
An audience with... Victoria G. Hale.
Nat Rev Drug Discov. 2005 Nov;4(11):878. doi: 10.1038/nrd1897.
8
PHARMACEUTICALS AND THE UMWA WELFARE AND RETIREMENT FUND IN TWO PENNSYLVANIA AREAS.宾夕法尼亚州两个地区的药品与美国矿工联合会福利及退休基金。
Am J Public Health Nations Health. 1965 Jan;55(1):81-7. doi: 10.2105/ajph.55.1.81.
9
New vaccines for developing countries: will it be feast or famine?面向发展中国家的新型疫苗：会是盛宴还是饥荒？
Am J Law Med. 2009;35(2-3):311-22. doi: 10.1177/009885880903500204.
10
Southeast Asia needs a revolving fund for vaccines.东南亚需要一个疫苗周转基金。
Lancet Glob Health. 2022 Nov;10(11):e1557-e1558. doi: 10.1016/S2214-109X(22)00406-5.

引用本文的文献

1
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.使用实际非劣效性界值的剂量优化试验中的样本量计算
Stat Med. 2025 May;44(10-12):e70118. doi: 10.1002/sim.70118.
2
Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers.患者、临床医生和指南制定者所认为的真实世界中患者报告的毒性症状监测对指南和护理的益处与局限性
Cancer Med. 2025 Apr;14(8):e70880. doi: 10.1002/cam4.70880.
3
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system.
延长间隔给药的预期环境和公共卫生效益：在美国国家卫生系统中使用帕博利珠单抗的分析。
Lancet Oncol. 2024 Jun;25(6):802-810. doi: 10.1016/S1470-2045(24)00200-6.
4
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer.整合治疗成本降低策略与生物标志物研究以降低成本并使昂贵治疗个性化：非小细胞肺癌自筹资金试验的一个实例。
Front Pharmacol. 2023 Nov 28;14:1274532. doi: 10.3389/fphar.2023.1274532. eCollection 2023.
5
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies.通过改变给药策略进行免疫检查点抑制剂的介入药物经济学
Br J Cancer. 2023 Oct;129(9):1389-1396. doi: 10.1038/s41416-023-02367-y. Epub 2023 Aug 4.
6
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access.优化癌症免疫检查点抑制剂的剂量和给药方案以实现全球可及。
Nat Med. 2022 Nov;28(11):2236-2237. doi: 10.1038/s41591-022-02029-1.